At Novartis – NGDx Oncology, I led concurrent Phase I–III oncology studies and related clinical-development initiatives, coordinating global teams and external providers from start-up through database lock and closeout.
I managed study budgets up to $18M and maintained timelines, risk tracking, quality oversight, and inspection readiness. Earlier, at NEWTON-WELLESLEY OBSTETRICS & GYNECOLOGY, I supported healthcare operations and Epic/EMR implementation.

